Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
SELL
Value
$9,203
Shares
47
Price
$195.8
Executed
Dec 1, 2025
Disclosed
Dec 3, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 1 executedDec 3, 2025 disclosed
LGND · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kozarich John W filed this Form 4 reporting a open-market sale of LGND on Dec 1, 2025. It became public on Dec 3, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kozarich John Wcik:0001223000
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
